Survival improvements with adjuvant therapy in patients with glioblastoma-Reference-Cited by-同舟云学术

Survival improvements with adjuvant therapy in patients with glioblastoma

Published:2017-09-18 Issue:3 Volume:88 Page:196-201
ISSN:1445-1433
Container-title:ANZ Journal of Surgery
language:en
Short-container-title:ANZ J Surg

Author:

Jayamanne Dasantha¹²,Wheeler Helen¹³⁴,Cook Raymond⁴⁵,Teo Charles⁶,Brazier David³⁷,Schembri Geoff³⁸,Kastelan Marina¹⁴,Guo Linxin¹,Back Michael F.¹²³⁴^ORCID

Affiliation:

1. Northern Sydney Cancer Centre; Royal North Shore Hospital; Sydney New South Wales Australia

2. Central Coast Cancer Centre; Gosford Hospital; Sydney New South Wales Australia

3. Sydney Medical School; The University of Sydney; Sydney New South Wales Australia

4. Sydney NeuroOncology Group; Sydney New South Wales Australia

5. Department of Neurosurgery; Royal North Shore Hospital; Sydney New South Wales Australia

6. Department of Neurosurgery; Prince of Wales Private Hospital; Sydney New South Wales Australia

7. Department of Radiology; Royal North Shore Hospital; Sydney New South Wales Australia

8. Department of Nuclear Medicine; Royal North Shore Hospital; Sydney New South Wales Australia

Publisher

Wiley

Subject

General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ans.14153/fullpdf

Reference20 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009

3. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial;Stupp;Lancet Oncol.,2014

4. A randomized trial of bevacizumab for newly diagnosed glioblastoma;Gilbert;N. Engl. J. Med.,2014

5. Australian Institute of Health and Welfare Australian Cancer Incidence and Mortality (ACIM) Books: Brain Cancer 2017 http://www.aihw.gov.au/acim-books/

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse;Journal of Neuro-Oncology;2024-03-29

2. A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy;Discover Oncology;2024-03-22

3. The MANGO study: a prospective investigation of oxygen enhanced and blood-oxygen level dependent MRI as imaging biomarkers of hypoxia in glioblastoma;Frontiers in Oncology;2023-12-19

4. Management and outcomes of glioblastoma: 20‐year experience in a single Australian institution;Journal of Medical Imaging and Radiation Oncology;2023-11-24

5. Association of MRI Volume Parameters in Predicting Patient Outcome at Time of Initial Diagnosis of Glioblastoma;Brain Sciences;2023-11-10